Kroczek Karolina, Kroczek Piotr, Nawrat Zbigniew
Department of Doctoral Studies, School of Public Health in Bytom, Medical University of Silesia in Katowice, Poland.
Biocybernetics Laboratory, Zbigniew Religa Foundation for Cardiac Surgery Development, Zabrze, Poland.
Kardiochir Torakochirurgia Pol. 2017 Mar;14(1):79-83. doi: 10.5114/kitp.2017.66939. Epub 2017 Mar 31.
Medical robots offer new standards and opportunities for treatment. This paper presents a review of the literature and market information on the current situation and future perspectives for the applications of robots in cardiac surgery. Currently in the United States, only 10% of thoracic surgical procedures are conducted using robots, while globally this value remains below 1%. Cardiac and thoracic surgeons use robotic surgical systems increasingly often. The goal is to perform more than one hundred thousand minimally invasive robotic surgical procedures every year. A surgical robot can be used by surgical teams on a rotational basis. The market of surgical robots used for cardiovascular and lung surgery was worth 72.2 million dollars in 2014 and is anticipated to reach 2.2 billion dollars by 2021. The analysis shows that Poland should have more than 30 surgical robots. Moreover, Polish medical teams are ready for the introduction of several robots into the field of cardiac surgery. We hope that this market will accommodate the Polish Robin Heart robots as well.
医疗机器人为治疗提供了新的标准和机遇。本文对机器人在心脏手术中的应用现状及未来前景的文献和市场信息进行了综述。目前在美国，仅10%的胸外科手术是使用机器人进行的，而在全球范围内，这一比例仍低于1%。心脏和胸外科医生越来越频繁地使用机器人手术系统。目标是每年进行超过十万例微创机器人手术。手术团队可以轮流使用手术机器人。2014年用于心血管和肺部手术的手术机器人市场价值7220万美元，预计到2021年将达到22亿美元。分析表明，波兰应该拥有30多台手术机器人。此外，波兰医疗团队已准备好在心脏手术领域引入多台机器人。我们希望这个市场也能接纳波兰的“罗宾之心”机器人。
